 <h1>Solriamfetol Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to solriamfetol: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, solriamfetol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking solriamfetol:</p><p>
<i>More common</i>
</p><ul>
<li>Anxiety</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Agitation</li>
<li>chest pain or discomfort</li>
<li>cough</li>
<li>fast, irregular, pounding, or racing heartbeat or pulse</li>
<li>feeling jittery</li>
<li>irritability</li>
<li>restlessness</li>
<li>tightness of the chest</li>
<li>tremor</li>
<li>trouble breathing</li>
<li>trouble sleeping</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of solriamfetol may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Decreased appetite</li>
<li>headache</li>
<li>nausea</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Clenching, gnashing, or grinding teeth</li>
<li>constipation</li>
<li>decreased weight</li>
<li>diarrhea</li>
<li>dizziness</li>
<li>dry mouth</li>
<li>increased sweating</li>
<li>stomach pain</li>
<li>vomiting</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to solriamfetol: oral tablet</i></p><h3>General</h3><p>The more commonly reported adverse reactions have included headache, nausea, decreased appetite, insomnia, and anxiety.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Increased systolic and diastolic blood pressure and heart rate occurred in a dose-dependent manner during clinical trials.</p><p><b>Common</b> (1% to 10%): Palpitations, chest discomfort/pain</p>
<p><b>Frequency not reported</b>: Increased blood pressure and heart rate</p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, anxiety (includes nervousness and panic attacks), irritability, jittery </p>
<p><b>Frequency not reported</b>: Agitation, restlessness</p><p>Anxiety was more commonly reported at higher doses.  Agitation and restlessness were reported in less than 2% of patients.</p><h3>Gastrointestinal</h3><p>Nausea, including vomiting, dry mouth, and vomiting were more common at higher doses.  Bruxism and thirst were reported in less than 2% of patients.</p><p><b>Common</b> (1% to 10%): Nausea (includes nausea and vomiting), dry mouth, constipation, diarrhea, abdominal pain </p>
<p><b>Frequency not reported</b>: Bruxism, thirst</p><h3>Metabolic</h3><p>Decreased appetite was more common at higher doses.  Decreased weight was reported in less than 2% of patients.</p><p><b>Common</b> (1% to 10%): Decreased appetite </p>
<p><b>Frequency not reported</b>: Decreased weight</p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Cough, dyspnea</p><p>Cough and dyspnea were reported in less than 2% of patients.</p><h3>Nervous system</h3><p>Headache was more common with higher doses.  Disturbances in attention and tremor were reported in less than 2% of patients.</p><p><b>Very common</b> (10% or more): Headache (16%) </p>
<p><b>Common</b> (1% to 10%): Dizziness</p>
<p><b>Frequency not reported</b>: Disturbances in attention, tremor</p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Hyperhidrosis</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Sunosi (solriamfetol)." Jazz Pharmaceuticals, Palo Alto, CA. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Is Sunosi (solriamfetol) a controlled substance?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about solriamfetol</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>25 Reviews</li>
<li>Drug class: miscellaneous central nervous system agents</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Solriamfetol &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Sunosi</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Obstructive Sleep Apnea/Hypopnea Syndrome</li>
<li>Narcolepsy</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to solriamfetol: oral tablet</i></p><h3>General</h3><p>The more commonly reported adverse reactions have included headache, nausea, decreased appetite, insomnia, and anxiety.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Increased systolic and diastolic blood pressure and heart rate occurred in a dose-dependent manner during clinical trials.</p><p><b>Common</b> (1% to 10%): Palpitations, chest discomfort/pain</p><p><b>Frequency not reported</b>: Increased blood pressure and heart rate</p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, anxiety (includes nervousness and panic attacks), irritability, jittery </p><p><b>Frequency not reported</b>: Agitation, restlessness</p><p>Anxiety was more commonly reported at higher doses.  Agitation and restlessness were reported in less than 2% of patients.</p><h3>Gastrointestinal</h3><p>Nausea, including vomiting, dry mouth, and vomiting were more common at higher doses.  Bruxism and thirst were reported in less than 2% of patients.</p><p><b>Common</b> (1% to 10%): Nausea (includes nausea and vomiting), dry mouth, constipation, diarrhea, abdominal pain </p><p><b>Frequency not reported</b>: Bruxism, thirst</p><h3>Metabolic</h3><p>Decreased appetite was more common at higher doses.  Decreased weight was reported in less than 2% of patients.</p><p><b>Common</b> (1% to 10%): Decreased appetite </p><p><b>Frequency not reported</b>: Decreased weight</p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Cough, dyspnea</p><p>Cough and dyspnea were reported in less than 2% of patients.</p><h3>Nervous system</h3><p>Headache was more common with higher doses.  Disturbances in attention and tremor were reported in less than 2% of patients.</p><p><b>Very common</b> (10% or more): Headache (16%) </p><p><b>Common</b> (1% to 10%): Dizziness</p><p><b>Frequency not reported</b>: Disturbances in attention, tremor</p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Hyperhidrosis</p><p id="ref_1">1. "Product Information. Sunosi (solriamfetol)." Jazz Pharmaceuticals, Palo Alto, CA. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Is Sunosi (solriamfetol) a controlled substance?</li>
</ul><h2>More about solriamfetol</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>25 Reviews</li>
<li>Drug class: miscellaneous central nervous system agents</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Solriamfetol &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Obstructive Sleep Apnea/Hypopnea Syndrome</li>
<li>Narcolepsy</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>